Alyeska Investment Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-167,208
| Closed | -$366K | – | 353 |
|
|
2019
Q2 | $366K | Buy |
+167,208
| New | +$366K | ﹤0.01% | 374 |
|
|
2018
Q3 | – | Sell |
-613,635
| Closed | -$12.3M | – | 361 |
|
|
2018
Q2 | $12.3M | Sell |
613,635
-238,139
| -28% | -$4.76M | 0.11% | 182 |
|
|
2018
Q1 | $14.9M | Buy |
851,774
+183,890
| +28% | +$3.22M | 0.12% | 178 |
|
|
2017
Q4 | $16.5M | Buy |
667,884
+200,000
| +43% | +$4.93M | 0.13% | 173 |
|
|
2017
Q3 | $12.1M | Buy |
467,884
+215,201
| +85% | +$5.55M | 0.09% | 215 |
|
|
2017
Q2 | $6.85M | Buy |
252,683
+59,726
| +31% | +$1.62M | 0.06% | 252 |
|
|
2017
Q1 | $5.75M | Buy |
192,957
+95,103
| +97% | +$2.84M | 0.05% | 291 |
|
|
2016
Q4 | $2.66M | Buy |
+97,854
| New | +$2.66M | 0.02% | 366 |
|